These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14329312)

  • 21. [LIVER AND BLOOD COAGULATION. II. ANTITHROMBIN AND ANTITHROMBOPLASTIN ACTIVITY IN LIVER PATIENTS].
    SOARDI F; BOLANDRINA E
    Gazz Int Med Chir; 1964 Jan; 68():185-93. PubMed ID: 14154378
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthetic low molecular weight inhibitors of thrombin.
    Geratz JD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):455-70. PubMed ID: 4121339
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticoagulant effect of sulphated poly/vinyl alcohol-acrylic acid/copolymers.
    Machovich R; Nagy M; Györgyi-Edelényi J; Csomor K; Horváth I
    Thromb Haemost; 1986 Dec; 56(3):397-400. PubMed ID: 2951893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin cofactor and plasma antithrombin in relation to the mechanism of inactivation of thrombin by heparin.
    Porter P; Porter MC; Shanberge JN
    Clin Chim Acta; 1967 Aug; 17(2):189-200. PubMed ID: 6035543
    [No Abstract]   [Full Text] [Related]  

  • 25. The micromolecular fibrinogen derivatives: fractionation by ultrafiltration and cation-exchange chromatography.
    Triantaphyllopoulos E
    Prep Biochem; 1973; 3(5):451-72. PubMed ID: 4271634
    [No Abstract]   [Full Text] [Related]  

  • 26. [BLOOD COAGULATION CHANGES AND THEIR RELATION TO THE EFFECT OF DRUGS IN HYPERTENSION].
    URBANIUK KG
    Kardiologiia; 1964; 4():45-8. PubMed ID: 14203916
    [No Abstract]   [Full Text] [Related]  

  • 27. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 28. BIOLOGIC PROPERTIES OF POLYNUCLEOTIDES. II. THE ANTICOAGULANT PROPERTIES OF POLYNUCLEOTIDES.
    YACHNIN S
    Blood; 1964 Nov; 24():553-66. PubMed ID: 14236730
    [No Abstract]   [Full Text] [Related]  

  • 29. Properties of thrombin and fibrinolysin lysed fibrin.
    Triantaphyllopoulos DC; Muirhead CR; Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1969; 36():269-76. PubMed ID: 5375545
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of the fibrinolytic enzyme system in laboratory animals and in man. A comparative study.
    Baillie AJ; Sim AK
    Thromb Diath Haemorrh; 1971 Jun; 25(3):499-506. PubMed ID: 4254504
    [No Abstract]   [Full Text] [Related]  

  • 31. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
    Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
    [No Abstract]   [Full Text] [Related]  

  • 32. ANTICOAGULANT ACTIVITY OF DIGEST PRODUCTS OF FIBRINOGEN BY PLASMIN.
    MAKI M; KIKUCHI I; MURAKAMI A
    Tohoku J Exp Med; 1964 Dec; 84():201-14. PubMed ID: 14242745
    [No Abstract]   [Full Text] [Related]  

  • 33. [THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM].
    SCHIMPF K; CIBELIUS A; MARDINI R
    Klin Wochenschr; 1964 Jul; 42():637-40. PubMed ID: 14248608
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of an acidic environment on coagulation dynamics.
    Gissel M; Brummel-Ziedins KE; Butenas S; Pusateri AE; Mann KG; Orfeo T
    J Thromb Haemost; 2016 Oct; 14(10):2001-2010. PubMed ID: 27431334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinolytic activities of euglobulins precipitated at pH 6.4,6.0, and 5.3.
    Hedlin AM; Monkhouse FC
    Can J Physiol Pharmacol; 1969 Nov; 47(11):935-40. PubMed ID: 4242858
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
    SAMAMA M
    Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287
    [No Abstract]   [Full Text] [Related]  

  • 38. [EFFECT OF SNAKE VENOMS ON BLOOD COAGULATION IN VITRO].
    KORNALIK F
    Acta Univ Carol Med (Praha); 1963; 9():149-88. PubMed ID: 14166155
    [No Abstract]   [Full Text] [Related]  

  • 39. Formation of anticoagulants by digesting fibrin with thrombin.
    Triantaphyllopoulos DC; Muirhead CR
    Thromb Diath Haemorrh; 1968 Jul; 19(3):397-402. PubMed ID: 5304346
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation.
    RATNOFF OD; HARTMANN RC; CONLEY CL
    J Exp Med; 1950 Feb; 91(2):123-33. PubMed ID: 15404220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.